ArticleBMJ open2023

Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial.

Lisa Mary Raven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.